Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
June 18, 2026
The U.S. Supreme Court ruled Thursday that a legal doctrine designed to curtail duplicative litigation prevents parties who lose in state court from appealing in federal district court even if the state case is still pending.
-
June 18, 2026
U.S. Supreme Court justices ruled Thursday that the federal government cannot bar gun ownership for a marijuana user solely because he used a controlled substance, saying that the prosecution of a Texas man for owning guns as an admitted marijuana user was inconsistent with the Second Amendment right to bear arms.
-
June 17, 2026
Eli Lilly & Co. urged the full Federal Circuit Wednesday to review a panel ruling that upheld Teva's $177 million jury verdict on headache drug patents, arguing that the panel's decision runs afoul of the justices' Amgen holding and "opens a truck-sized hole in enablement and written description law."
-
June 17, 2026
The U.S. Supreme Court's decision this month that shut down a patent suit against Hikma Pharmaceuticals USA over a drug using a so-called skinny label could also make it more challenging to plead induced infringement in cases involving other technologies, attorneys say.
-
June 17, 2026
Supermarket chain Giant Eagle on Wednesday hit insurance brokerage firm Aon with claims in Pennsylvania federal court that it jeopardized $40 million in coverage allegedly owed to the chain for settlement and defense costs in opioid litigation.
See more Life Sciences news